Clorox Co
11 nominees · 3 ballot items.
Three proposals are being voted on at The Clorox Company's annual meeting: Proposal 1 – Election of 11 director nominees; Proposal 2 – Advisory vote to approve executive compensation (say-on-pay); and Proposal 3 – Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
Follow how the vote landed and what changed on Clorox Co’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of the 11 director nominees named in the proxy to serve on the Board until the 2026 Annual Meeting of Shareholders and until their successors are duly elected and qualified.
- 2
Advisory Vote to Approve Executive Compensation
ManagementBoard: FORNon-binding advisory vote on the compensation of the Company’s named executive officers for fiscal year 2025 (often referred to as a say-on-pay vote).
- 3
Ratification of Independent Registered Public Accounting Firm
ManagementBoard: FORRatification of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
Nominees on the ballot11
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | STATE STREET CORP | 6.8% | 8,254,575 | $855M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 7,850,437 | $814M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8% | 5,784,592 | $599M |
| 4 | BlackRock, Inc. | 3.6% | 4,309,029 | $447M |
| 5 | VAN ECK ASSOCIATES CORP | 2.7% | 3,218,379 | $334M |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 2,839,760 | $293M |
| 7 | Invesco Ltd. | 2.2% | 2,662,305 | $276M |
| 8 | BlackRock, Inc. | 2.0% | 2,468,428 | $256M |
| 9 | Invesco Ltd. | 1.6% | 1,891,636 | $196M |
| 10 | Point72 Asset Management, L.P.Activist | 1.3% | 1,592,288 | $165M |
Other Consumer Defensive sector meetings6
Upcoming shareholder meetings at Clorox Co’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Clorox Co 2025 annual meeting?
- Clorox Co (CLX) holds its 2025 annual shareholder meeting on Wednesday, November 19, 2025.
- What is the record date for the Clorox Co 2025 meeting?
- The record date for the Clorox Co 2025 meeting is Monday, September 22, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Clorox Co's 2025 meeting?
- The board is presenting 11 director nominees at the Clorox Co 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Clorox Co 2025 meeting?
- Shareholders will vote on 3 proposals at the Clorox Co 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.